MAPT and Alzheimer disease: There is also the GSK-3β hypothesis which states that it is due to the “over-activity of GSK3β accounts for memory impairment, tau hyper-phosphorylation, increased β-amyloid production and local plaque-associated microglial-mediated inflammatory responses” observed in AD [12, 20–22].